RIVAROXABAN | A218117 | SCIEGEN PHARMACEUTICALS INC
Highest NADAC/Unit
$0.7967
per ea
Lowest NADAC/Unit
$0.7967
per ea
Brand NDCs
0
Generic NDCs
4
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 76282077418RIVAROXABAN 2.5 MG TABLET | $0.7967 | EA | Generic | — | 2026-06-17 |
| 76282077460RIVAROXABAN 2.5 MG TABLET | $0.7967 | EA | Generic | — | 2026-06-17 |
| 50228051318RIVAROXABAN 2.5 MG TABLET | $0.7967 | EA | Generic | — | 2026-06-17 |
| 50228051360RIVAROXABAN 2.5 MG TABLET | $0.7967 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.